Optimind Pharma Corp. (CSE:OMND)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
At close: Sep 11, 2025

Optimind Pharma Revenue

Optimind Pharma had revenue of 34.03K CAD in the quarter ending November 30, 2025, with 28.12% growth. This brings the company's revenue in the last twelve months to 131.48K, up 18.10% year-over-year. In the fiscal year ending February 28, 2025, Optimind Pharma had annual revenue of 118.37K, down -3.73%.

Revenue (ttm)
131.48K
Revenue Growth
+18.10%
P/S Ratio
3.92
Revenue / Employee
n/a
Employees
n/a
Market Cap
515.74K

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Feb 28, 2025118.37K-4.59K-3.73%
Feb 29, 2024122.96K-47.15K-27.72%
Feb 28, 2023170.11K70.42K70.64%
Feb 28, 202299.69K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition